MicroRNA-based therapeutics developer InteRNA Technologies has closed an extended Series B round totaling...
Up To Date
Latest News
The German Health Ministry has requested €6.2bn from the Federal Ministry of Finance to purchase up to 635...
V-Bio Ventures has announced the first closing of its V-Bio Fund 2 at €78m. The fund is focussed on...
The transatlantic Abingworth Bioventures 8 Fund has been closed at $464m to invest in US, UK and European life...
As rapidly spreading mutants of SARS-CoV-2 are emerging, two Tuebingen-based vaccine developers will develop...
German CDMO Rentschler Biopharma is expanding cCMP production of CureVac NV’s RNA-based COVID-19 vaccine...